Annual report pursuant to Section 13 and 15(d)

Cover

v3.24.2.u1
Cover - USD ($)
12 Months Ended
Apr. 30, 2024
Apr. 30, 2023
Aug. 08, 2024
Oct. 31, 2023
Cover [Abstract]        
Document Type 10-K      
Amendment Flag false      
Document Annual Report true      
Document Transition Report false      
Document Period End Date Apr. 30, 2024      
Document Fiscal Period Focus FY      
Document Fiscal Year Focus 2024      
Current Fiscal Year End Date --04-30      
Entity File Number 001-40699      
Entity Registrant Name PHARMACYTE BIOTECH, INC.      
Entity Central Index Key 0001157075      
Entity Tax Identification Number 62-1772151      
Entity Incorporation, State or Country Code NV      
Entity Address, Address Line One 3960 Howard Hughes Parkway      
Entity Address, Address Line Two Suite 500      
Entity Address, City or Town Las Vegas      
Entity Address, State or Province NV      
Entity Address, Postal Zip Code 89169      
City Area Code 917      
Local Phone Number 595-2850      
Title of 12(b) Security Common Stock, Par Value $0.0001 Per Share      
Trading Symbol PMCB      
Security Exchange Name NASDAQ      
Entity Well-known Seasoned Issuer No      
Entity Voluntary Filers No      
Entity Current Reporting Status Yes      
Entity Interactive Data Current Yes      
Entity Filer Category Non-accelerated Filer      
Entity Small Business true      
Entity Emerging Growth Company false      
Entity Shell Company false      
Entity Public Float       $ 18,203,997
Entity Common Stock, Shares Outstanding     7,709,459  
ICFR Auditor Attestation Flag false      
Document Financial Statement Error Correction [Flag] false      
Auditor Firm ID 688 32    
Auditor Name Marcum LLP Armanino LLP    
Auditor Location East Hanover, New Jersey Irvine, California